Mina S Sedrak

University Of California Los Angeles

$3,437,312

Attributed

$3,437,312

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY2019–25

$2M$1.5M$1M$500K$0

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$3,437,312 · 4

By mechanism

R01$2,026,604 · 1

K76$728,995 · 1

R21$422,213 · 1

R03$259,500 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of California Los Angeles

Same institution · by research overlap

Yi Tang$19,359,331
Hosea Martin Nelson$3,232,830
Kendall N Houk$14,756,097
Neil K Garg$10,375,151
Jonathan Wanagat$4,707,141

Others in their field

Other Emerging Leaders on “Malignant Neoplasms”

Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
Martha Hering · Westat, Inc.$57,098,843

Research focus

Malignant NeoplasmsCancer PatientOralAgingSecondary EndpointBiological MarkersSenescenceInflammationRandomizedLinkChemotherapyPhysical FunctionFrailtyCancer TherapyGrowthPrimary EndpointDietary SupplementsFisetinRandomized Placebo Controlled TrialCell AgingCdkn2a GeneInflammatoryCessation Of LifeSurvivors